{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:27Z","timestamp":1792788507357,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Southern California","id":[{"id":"https:\/\/ror.org\/03taz7m60","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>For many years, large, multifocal\/multicentric tumors have routinely been treated with mastectomy. Extreme oncoplastic breast-conserving surgery attempts to achieve complete oncologic resection of large tumors while preserving the natural shape, symmetry, and function of breasts. This paper compares recurrence and survival probabilities for extreme and standard (\u226450 mm) tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective oncoplastic database accrued between 2008 and 2025 was queried for patients with breast cancer treated with reduction mammoplasty and whole breast irradiation. In total, 340 patients with extreme tumors &gt;50 mm were compared with 378 patients with standard tumors \u226450 mm. Demographic and biologic factors and recurrence and survival probabilities were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Biologic factors were statistically similar for both groups. Negative margins, defined as no ink on tumor, were achieved in 96.8% of standard and 92.6% of extreme cases (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.01). Mean tumor span was 26.3 mm for standard and 74.3 mm for extreme cases (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). Re-excision rates were 5.6 and 10.9%, for standard and extreme cases, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.01). The 5-year local recurrence probability was 1.44% for standard cases versus 3.37% for extreme cases (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.067). Distant recurrence, breast cancer-specific survival, and overall survival did not differ significantly.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Extreme oncoplasty followed by whole\u00a0breast irradiation allows safe breast conservation in selected patients with large, &gt;50 mm, multifocal\/multicentric tumors, achieving local and distant recurrence and survival outcomes comparable to those of standard oncoplastic cases. When technically feasible, breast conservation with extreme oncoplastic reconstruction should be considered a valid alternative to mastectomy in appropriately selected patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20139-9","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:29:24Z","timestamp":1783963764000},"page":"9877-9883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extreme Oncoplasty: Avoiding Mastectomy and Expanding the Limits of Breast Conservation\u2014A Comparative Study of 718 Patients"],"prefix":"10.1245","volume":"33","author":[{"given":"Jenna","family":"Capuano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin J.","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav","family":"Savalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"20139_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jamasurg.2021.1438","volume":"156","author":"JSR Boniface","year":"2021","unstructured":"Boniface J, Szulkin R, Johansson ALV. Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women. JAMA Surg. 2021;156:628\u201337.","journal-title":"JAMA Surg."},{"key":"20139_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamasurg.2013.3049","volume":"149","author":"SPL Agarwal","year":"2014","unstructured":"Agarwal S, Pappas L, Neumayer L, et al. Effect of Breast Conservation Therapy vs Mastectomy on Disease-Specific Survival for Early-Stage Breast Cancer. JAMA Surg. 2014;149:267\u201374.","journal-title":"JAMA Surg."},{"key":"20139_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/tbj.12356","volume":"21","author":"MJ Silverstein","year":"2015","unstructured":"Silverstein MJ, Savalia N, Khan S, Ryan J. Extreme Oncoplasty: Breast Conservation for Patients Who Need Mastectomy. Breast J. 2015;21:52\u20139.","journal-title":"Breast J."},{"key":"20139_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jamcollsurg.2015.10.007","volume":"222","author":"MJ Silverstein","year":"2016","unstructured":"Silverstein MJ. Radical Mastectomy to Radical Conservation (Extreme Oncoplasty): A Revolutionary Change. J Am Coll Surg. 2016;222:1\u20139.","journal-title":"J Am Coll Surg."},{"issue":"10","key":"20139_CR5","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1245\/s10434-015-4671-4","volume":"22","author":"MJ Silverstein","year":"2015","unstructured":"Silverstein MJ, Savalia N, Khan S, et al. Oncoplastic split reduction with intraoperative radiation therapy. Ann Surg Oncol. 2015;22(10):3405\u20136.","journal-title":"Ann Surg Oncol."},{"key":"20139_CR6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233\u201341.","journal-title":"N Engl J Med."},{"key":"20139_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1056\/NEJM198503143121101","volume":"312","author":"B Fisher","year":"1985","unstructured":"Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without radiation therapy in the treatment of breast cancer. N Eng J Med. 1985;312:665\u201373.","journal-title":"N Eng J Med."},{"key":"20139_CR8","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa020989","volume":"347","author":"U Veronesi","year":"2002","unstructured":"Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227\u201332.","journal-title":"N Engl J Med."},{"key":"20139_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1056\/NEJM198107023050102","volume":"305","author":"U Veronesi","year":"1981","unstructured":"Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981;305:6\u201310.","journal-title":"N Engl J Med"},{"key":"20139_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.amjsurg.2019.01.004","volume":"217","author":"ALR Crown","year":"2019","unstructured":"Crown A, Laskin R, Rocha FG, Grumley J. Extreme oncoplasty: Expanding indications for breast conservation. Am J Surg. 2019;217:851\u20136.","journal-title":"Am J Surg."},{"key":"20139_CR11","first-page":"353","volume":"13","author":"FSS Savioli","year":"2021","unstructured":"Savioli F, Seth S, Morrow E, et al. Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer. Breast Cancer. 2021;13:353\u201359.","journal-title":"Breast Cancer."},{"issue":"1","key":"20139_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejso.2019.09.004","volume":"46","author":"BCSFR Pearce","year":"2020","unstructured":"Pearce BCS, Fiddes RN, Paramanathan N, Chand N, Laws SAM, Rainsbury RM. Extreme oncoplastic conservation is a safe new alternative to mastectomy. Eur J Surg Oncol. 2020;46(1):71\u20136.","journal-title":"Eur J Surg Oncol."},{"issue":"13","key":"20139_CR13","doi-asserted-by":"publisher","first-page":"1215284","DOI":"10.3389\/fonc.2023.1215284","volume":"30","author":"RADC Vieira","year":"2024","unstructured":"Vieira RADC, Paulinelli RR, de Oliveira-Junior I. Extreme oncoplasty: past, present and future. Front Oncol. 2024;30(13):1215284. https:\/\/doi.org\/10.3389\/fonc.2023.1215284.","journal-title":"Front Oncol."},{"key":"20139_CR14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/wjs.12521","volume":"49","author":"K Shaikh","year":"2025","unstructured":"Shaikh K, Arif A, Mooghal M, Mushtaque Vohra L. Promoting Oncological Safety: Extreme Oncoplasty as an Alternative to Mastectomy\u2014Insights From a Single-Center Experience in Low and Middle-Income Country. World J Surg. 2025;49:789\u201396. https:\/\/doi.org\/10.1002\/wjs.12521.","journal-title":"World J Surg."},{"key":"20139_CR15","doi-asserted-by":"publisher","first-page":"7284","DOI":"10.1245\/s10434-024-15791-y","volume":"31","author":"D Hossino","year":"2024","unstructured":"Hossino D, Silverstein MJ, Savalia N, Jayich M, Khan S. Extreme Oncoplasty: Oncologically Safe When Compared with Mastectomy. Ann Surg Oncol. 2024;31:7284\u20138.","journal-title":"Ann Surg Oncol."},{"key":"20139_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.suronc.2020.11.001","volume":"35","author":"ABL Bazzarelli","year":"2020","unstructured":"Bazzarelli A, Baker L, Petrcich W, Zhang J, Arnaout A. Patient Satisfaction Following Level II Oncoplastic Breast Surgery: A Comparison with Mastectomy Utililizing the Breast-Q Questionnaire. Surg Oncol. 2020;35:556\u20139.","journal-title":"Surg Oncol."},{"key":"20139_CR17","doi-asserted-by":"publisher","first-page":"6e","DOI":"10.1097\/PRS.0000000000012262","volume":"157","author":"RLLJ Shammas","year":"2026","unstructured":"Shammas RL, Levy J, Boe LA, et al. Risk of Radiation-Induced Capsular Contracture following Subpectoral or Prepectoral Implant-Based Breast Reconstruction. Plast Reconstr Surg. 2026;157:6e\u201314e.","journal-title":"Plast Reconstr Surg."},{"key":"20139_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/cancers16020265","volume":"16","author":"M Vinsensia","year":"2024","unstructured":"Vinsensia M, Schaub R, Meixner E, et al. Incidence and Risk Assessment of Capsular Contracture in Breast Cancer Patients following Post-Mastectomy Radiotherapy and Implant-Based Reconstruction. Cancers. 2024;16:265\u201379.","journal-title":"Cancers."},{"issue":"6","key":"20139_CR19","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/PRS.0000000000001278","volume":"135","author":"PGAC Cordeiro","year":"2015","unstructured":"Cordeiro PG, Albornoz CR, McCormick B, Hu Q, Van Zee K. What is the optimum timing of postmastectomy radiotherapy in two-stage prosthetic reconstruction: radiation to the tissue expander or permanent implant? Plast Reconstr Surg. 2015;135(6):1509\u201317.","journal-title":"Plast Reconstr Surg."},{"issue":"1","key":"20139_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10549-011-1401-x","volume":"127","author":"MKM Barry","year":"2011","unstructured":"Barry M, Kell MR. Radiotherapy and breast reconstruction: a meta-analysis. Breast Cancer Res Treat. 2011;127(1):15\u201322.","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"20139_CR21","doi-asserted-by":"publisher","first-page":"e220631","DOI":"10.1001\/jamasurg.2022.0631","volume":"157","author":"SELX Hanson","year":"2022","unstructured":"Hanson SE, Lei X, Roubaud MS, et al. Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction. JAMA Surg. 2022;157(6):e220631.","journal-title":"JAMA Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20139-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:50:27Z","timestamp":1790916627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20139-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20139"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20139-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}